iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,601 shares of the financial services provider’s stock after selling 6,818 shares during the period. Commonwealth Equity Services LLC owned approximately 0.37% of iShares Biotechnology ETF worth $22,952,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in IBB. Aptus Capital Advisors LLC boosted its position in iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after purchasing an additional 114 shares in the last quarter. Huntington National Bank boosted its position in shares of iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares in the last quarter. OneDigital Investment Advisors LLC grew its stake in iShares Biotechnology ETF by 32.7% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 10,805 shares of the financial services provider’s stock valued at $1,573,000 after acquiring an additional 2,661 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in iShares Biotechnology ETF by 354.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 48,476 shares of the financial services provider’s stock valued at $7,058,000 after acquiring an additional 37,814 shares in the last quarter. Finally, LMR Partners LLP acquired a new position in iShares Biotechnology ETF during the third quarter worth about $4,904,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $134.19 on Monday. The firm’s 50-day moving average is $136.25 and its two-hundred day moving average is $139.76. The company has a market capitalization of $6.34 billion, a PE ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.